Association of Carcinoembryonic Antigen Reduction With Progression-free and Overall Survival Improvement in Advanced Non-small-cell Lung Cancer

Oscar Arrieta,Edgar Varela-Santoyo,Andrés F. Cardona,Roberto Sánchez-Reyes,Luis Lara-Mejía,Suraj Samtani Bassarmal, Dafne Valle-Bautista,Luis Corrales-Rodríguez,Daniel Motola-Kuba,Luis Cabrera-Miranda,Claudio Martín

Clinical Lung Cancer（2021）

引用 5|浏览8

暂无评分

摘要

In patients with metastatic non-small cell lung cancer with an elevated baseline CEA level, the percentage decrease of CEA concentrations above the threshold during the first-line therapy was associated with more prolonged survival and progression-free intervals. Serum CEA determinations are a feasible, noninvasive option for monitoring and prognosis.

查看译文

关键词

NSCLC,Tumor markers,Biomarker, lung cancer,CEA percentage decrease

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要